ETHRA Announces Science Partners

Posted 8th April 2020 by Dave Cross
European Tobacco Harm Reduction Advocates (ETHRA) has announced that it has new scientific partners. The umbrella organisation has members throughout Europe that campaign on vaping and harm reduction issues. It delightedly announced three new scientific partners.

ETHRA is an umbrella body for European nicotine consumer groups. It has been exceptionally active during its brief time since its inception and hopes that the addition of the three new science partners will add yet more weight to its powerful arguments.

Partner number one is Frank Baeyens, a professor of experimental psychology at KU Leuven, Belgium. He is an author of over 120 scientific papers on human learning and on a variety of experimental psychopathology topics. Baeyens developed a research line focusing on nicotine use, preference, and dependence, smoking and smoking cessation, electronic cigarettes, and other low-risk nicotine products over the last eight years.

Professor Baeyens is currently investigating vaping’s efficacy in controlled lab studies, clinical trials, observational studies and survey research. His work on vaping is featured regularly in national and international media outlets, he is a member of the e-cig advisory committee of the Superior Health Council (Belgium), and an instructor in the first KULeuven MOOC focusing on electronic cigarettes.

Dr Jacques le Houezec has featured in a number of articles on Planet of the Vapes [link]. He trained as a neuroscientist before moving to San Francisco to train in Clinical Pharmacology. Dr le Houezec has been a world-leading expert in nicotine and cessation for more almost four decades. More than just a smoking cessation expert, he now trains and certifies vape shops and health professionals.

The third science partner is Austria’s Bernd Mayer. With a background in chemistry and physics, Dr Mayer has worked at the Department of Pediatrics of the University Hospital, as a research assistant at the Department of Pharmacology and Toxicology on the role of cyclic GMP in blood vessels, and at the Department of Pharmacology at the Free University of Berlin, where he worked on the identification and characterization of nitric oxide synthases.


After returning to Graz, he focused on the molecular pharmacology of nitric oxide/cGMP signaling in the cardiovascular system. Dr Mayer has published over 300 scientific papers and has received several prestigious research prizes and was promoted to Full Professor and Chair of Pharmacology in 1999. In 2010 he was elected Corresponding Member of the Austrian Academy of Sciences.

Like Professor Baeyens and Dr Jacques le Houezec, Bernd Mayer has been advocating for electronic cigarettes for tobacco harm reduction in public lectures, written reports and official hearings with diverse political bodies.


  • ETHRA website – [link]
  • ETHRA Twitter – [link]

 Dave Cross
Article by Dave Cross
Freelance writer, physicist, karateka, dog walker